Recursion Pharmaceuticals
Carl Brooks has over 18 years of experience in the field of chemistry, currently serving as Senior Director of Chemistry at Recursion since September 2019. Prior to this role, Carl held various positions at GSK from January 2005 to September 2019, including Investigator, Scientist, and previously as an Industrial Placement Student. Throughout this extensive career, Carl has demonstrated strong expertise and leadership in chemical research and development.
Recursion Pharmaceuticals
13 followers
Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease.